Journal of Psychopharmacology · 2002 · 25 citations · 3 references
MedicinePharmacologyPharmacotherapyGastroenterologyPsychiatric PharmacotherapyPsychopharmacologyAntipsychotic PharmacotherapyAntipsychotic TherapyPancreatic DiseasesPancreatic PathologySchizophrenia PharmacotherapySchizophrenia Spectrum DisordersAntipsychotic Medication ManagementAtypical Antipsychotic TreatmentEnzymesExocrine Pancreatic DiseaseExocrine Pancreatic DysfunctionPancreatic Digestive EnzymesPancreatobiliary DisordersTreatment-resistant Psychosis
Clozapine, the first atypical antipsychotic, is indicated for the treatment of therapy-resistant schizophrenia. It needs to be monitored closely because of its well-known potential side-effects, especially agranulocytosis. We present a case of a middle-aged woman with chronic schizophrenia, who was treated with clozapine and developed a clinical syndrome of asymptomatic pancreatitis and eosinophilia within the fifth week of treatment. Asymptomatic pancreatitis has rarely been reported up to now and is not recognized as a typical side-effect of clozapine. In our opinion, pancreatic enzymes should be monitored especially in the first 6 weeks of clozapine treatment.
3
Gatto Em, Castronuovo Ap, Uribe Roca · PubMed · 1998 · 24 citations
Clozapine-Induced Eosinophilia
Michael Lucht, Marcella Rietschel · The Journal of Clinical Psychiatry · 1998 · 22 citations · Full text
Clozapine-Associated Pancreatitis
Theresa R. Cerulli · Harvard Review of Psychiatry · 1999 · 22 citations